Lack of predictive value of potential doubling time and iododeoxyuridine labelling index in radiotherapy of squamous cell carcinoma of the head and neck
- 1 February 1998
- journal article
- Published by Elsevier BV in Radiotherapy and Oncology
- Vol. 46 (2), 147-155
- https://doi.org/10.1016/s0167-8140(97)00168-0
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancerRadiotherapy and Oncology, 1997
- The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapyRadiotherapy and Oncology, 1996
- Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 GY in 7 weeksInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Potential pitfalls in the use of p-values and in interpretation of significance levelsRadiotherapy and Oncology, 1994
- Accelerated versus conventional fractionation in the postoperative irradiation of locally advanced head and neck cancer: influence of tumour proliferationRadiotherapy and Oncology, 1992
- Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neckBritish Journal of Cancer, 1992
- Predictive value of potential doubling time for radiotherapy of head and neck tumor patients: Results from the EORTC cooperative trial 22851Seminars in Radiation Oncology, 1992
- Cell proliferation and differentiation in squamous cancerRadiotherapy and Oncology, 1989
- Human tumour cell kinetics using a monoclonal antibody against iododeoxyuridine: Intratumour sampling variationsRadiotherapy and Oncology, 1988
- A method to measure the duration of DNA syntheses and the potential doubling time from a single sampleCytometry, 1985